Published in Cancer Weekly, August 7th, 2007
Roger White, President and CEO of Theralase Technologies Inc. stated that, "This is a significant milestone for the Company, which further expands research and development of the combined photodynamic compounds and laser technology for the selective destruction of...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.